Six new IPOPI PID information leaflets published

PIDs and Skin, PIDs and Cancer, Hyper IgE Syndrome, Ataxia-Telangiectasia, A Guide for Hepatologists and Genetic Diagnosis of PIDs

More PID diagnostic tests included in the WHO EDL

For the second year in a row, tests for diagnosing primary immunodeficiencies (PIDs) have been included in this Model List.

IPOPI launches new strategic plan

In the last 24 months, IPOPI undertook a thorough and comprehensive process to develop its new 5-year strategic plan for the 2021-2025 period.

COVID-19 Learning Expedition Report released

, ,

IPOPI launched the COVID-19 Learning Expedition (LEX) in July 2020, to identify, analyse and provide recommendations on issues brought about by the COVID-19 pandemic for patients with primary immunodeficiency (PID).

IPOPI’s PID Life Index – the PID environment around the globe

An interactive tool built on 6 key principles of care that measures the status of the PID healthcare environment across the globe